Literature DB >> 3881538

Human antibody to the group-specific polysaccharide of group B Streptococcus.

B F Anthony, N F Concepcion, K F Concepcion.   

Abstract

IgG antibody to purified group polysaccharide of group B Streptococcus was detected with a specific, reproducible enzyme-linked immunosorbent assay in sera of 178 human subjects: 106 parturient patients, 67 of their healthy infants, and 5 adults with invasive infection. Antibody concentrations in 44 parturient carriers of group B streptococci were significantly greater than in 44 noncarriers (geometric mean level, 3.5 and 1.2 micrograms/ml, respectively). Cord serum levels agreed closely with maternal serum levels. The sera of 18 mothers of infants with early-onset streptococcal infection contained levels (geometric mean level, 5.5 micrograms/ml) similar to those of carriers and significantly higher than noncarriers. Of five adults with invasive group B streptococcal infection, three demonstrated significant increases in antibody titer in consecutive sera, and four had antibody concentrations greater than most (93%) noncarriers. These findings suggest that group B polysaccharide is immunogenic in humans and that levels of specific IgG antibody increase with colonization or infection of adults with group B streptococci.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881538     DOI: 10.1093/infdis/151.2.221

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Isotype antibody response in cows to Streptococcus agalactiae group B polysaccharide-ovalbumin conjugate.

Authors:  P Rainard
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Authors:  M B Marques; D L Kasper; A Shroff; F Michon; H J Jennings; M R Wessels
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.

Authors:  M Granström; B Wretlind; B Markman; S Cryz
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

5.  Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model.

Authors:  D P Greenberg; A S Bayer; A L Cheung; J I Ward
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

6.  Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.

Authors:  H V Raff; P J Siscoe; E A Wolff; G Maloney; W Shuford
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.